DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,109 filers reported holding DANAHER CORPORATION in Q4 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $209 | -4.1% | 844 | -7.2% | 0.14% | -2.8% |
| Q2 2023 | $218 | -3.1% | 909 | +1.9% | 0.14% | -6.0% |
| Q1 2023 | $225 | -23.7% | 892 | -19.8% | 0.15% | -25.7% |
| Q4 2022 | $295 | -99.9% | 1,112 | 0.0% | 0.20% | -9.0% |
| Q3 2022 | $287,000 | +1.8% | 1,112 | 0.0% | 0.22% | +8.3% |
| Q2 2022 | $282,000 | -13.5% | 1,112 | 0.0% | 0.20% | -1.4% |
| Q1 2022 | $326,000 | -5.2% | 1,112 | +6.2% | 0.21% | -7.6% |
| Q4 2021 | $344,000 | +14.7% | 1,047 | +6.1% | 0.22% | +3.2% |
| Q3 2021 | $300,000 | +13.2% | 987 | 0.0% | 0.22% | +18.5% |
| Q2 2021 | $265,000 | +19.4% | 987 | 0.0% | 0.18% | +10.2% |
| Q1 2021 | $222,000 | +1.4% | 987 | 0.0% | 0.17% | -4.6% |
| Q4 2020 | $219,000 | -7.2% | 987 | -10.0% | 0.18% | -14.2% |
| Q3 2020 | $236,000 | +21.6% | 1,097 | 0.0% | 0.20% | +24.4% |
| Q2 2020 | $194,000 | +7.8% | 1,097 | -15.4% | 0.16% | -7.3% |
| Q1 2020 | $180,000 | -9.5% | 1,297 | 0.0% | 0.18% | +12.7% |
| Q4 2019 | $199,000 | +6.4% | 1,297 | 0.0% | 0.16% | +4.0% |
| Q3 2019 | $187,000 | +1.1% | 1,297 | 0.0% | 0.15% | -6.8% |
| Q2 2019 | $185,000 | +8.2% | 1,297 | 0.0% | 0.16% | +8.0% |
| Q1 2019 | $171,000 | +23.0% | 1,297 | -3.7% | 0.15% | +7.9% |
| Q4 2018 | $139,000 | -4.8% | 1,347 | 0.0% | 0.14% | +10.3% |
| Q3 2018 | $146,000 | +9.8% | 1,347 | 0.0% | 0.13% | +5.9% |
| Q2 2018 | $133,000 | -99.9% | 1,347 | -4.3% | 0.12% | -4.8% |
| Q1 2018 | $137,759,000 | -7.6% | 1,407 | -12.4% | 0.12% | +0.8% |
| Q4 2017 | $149,162,000 | +8.2% | 1,607 | 0.0% | 0.12% | +5.1% |
| Q3 2017 | $137,848,000 | +1.6% | 1,607 | 0.0% | 0.12% | +0.9% |
| Q2 2017 | $135,615,000 | -1.3% | 1,607 | 0.0% | 0.12% | -4.1% |
| Q1 2017 | $137,447,000 | -14.6% | 1,607 | -22.3% | 0.12% | -18.7% |
| Q4 2016 | $160,895,000 | – | 2,067 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |